Screener
CapEx at other companies
Other financials
Where this comes from
Reported directly by Viridian Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.
The source filing: Viridian Therapeutics, Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 7:31 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001590750-26-000018
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Cash flows from investing activities: | ||
| Purchases of marketable securities | (469,975) | (126,998) |
| Maturities of marketable securities | 317,408 | 302,906 |
| Purchase of property and equipment | (1,329) | (128) |
| Net cash provided by (used in) investing activities | (153,896) | 175,780 |
| Cash flows from financing activities: | ||
| Proceeds from the sale of convertible notes | 250,000 | — |
| Proceeds from the issuance of common stock in offerings | 143,750 | — |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Viridian Therapeutics, Inc.'s capex?
- Viridian Therapeutics, Inc. (VRDN) reported capex of $1.31M in Q2 2026.
- How has Viridian Therapeutics, Inc.'s capex changed year-over-year?
- Viridian Therapeutics, Inc.'s capex increased by 3009.5% year-over-year, from $42K to $1.31M.
- What is the long-term trend for Viridian Therapeutics, Inc.'s capex?
- Over 4 years (2021 to 2025), Viridian Therapeutics, Inc.'s capex has grown at a 10.0% compound annual growth rate (CAGR), from $338K to $495K.
- What does capex mean?
- Cash spent on property, plant, and equipment — the primary measure of investment in productive capacity and infrastructure.
Ask your AI about Viridian Therapeutics, Inc.'s capex.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude